Financing Diligence icon 2

FINANCING & DILIGENCE

Whether you are a company seeking funding or an investor considering an investment in the Cell and Gene Therapy space, DHC has the expertise to support your needs.  Our most common offerings in the area of Financing and Diligence include:

Due Diligence:
We are frequently called upon by investors to perform due diligence on companies in the Cell and Gene Therapy space.  Alternatively, for companies seeking investment, our mock diligence service can help ensure you are prepared for questions investors may raise.

Message Optimization:
Our unique combination of deep technical expertise and investor relations experience allows us to provide a candid assessment of your program and strategic planning for an optimal ‘pitch’.

Bespoke Introductions:
We maintain continuous awareness of investors with interest in the Cell and Gene Therapy space, allowing us to provide introductions to motivated investors for high quality companies seeking funding.

Financing and Diligence
Financing

Whether you are a company seeking funding or an investor considering an investment in the Cell and Gene Therapy space, DHC has the expertise to support your needs.  Our most common offerings in the area of Financing and Diligence include:

Due Diligence:
We are frequently called upon by investors to perform due diligence on companies in the Cell and Gene Therapy space.  Alternatively, for companies seeking investment, our mock diligence service can help ensure you are prepared for questions investors may raise.

Due Diligence

Message Optimization:
Our unique combination of deep technical expertise and investor relations experience allows us to provide a candid assessment of your program and strategic planning for an optimal ‘pitch’.

Financing

Bespoke Introductions:
We maintain continuous awareness of investors with interest in the Cell and Gene Therapy space, allowing us to provide introductions to motivated investors for high quality companies seeking funding.